Triple intrathecal therapy alone with omission of cranial radiation in children with acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 32, Issue 17, 2014, Pages 1825-1829

  Liu, Hsi Che ^a,b   Yeh, Ting Chi ^a,b   Hou, Jen Yin ^a,b   Chen, Kuan Hao ^b   Huang, Ting Huan ^b   Chang, Ching Yi ^b   Liang, Der Cherng ^a,b  

^a MACKAY MEDICAL COLLEGE   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; DASATINIB; EPIRUBICIN; IDARUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE DRUG REACTION; ARTICLE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; EVENT FREE SURVIVAL; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; INTRATHECAL DRUG ADMINISTRATION; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUMBAR PUNCTURE; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RELAPSE; SKULL IRRADIATION; STANDARD;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; FEMALE; HUMANS; INFANT; INJECTIONS, SPINAL; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84905862146     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.5020     Document Type: Article

References (27)

1. Aur RJ, Simone J, Hustu HO, et al: Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood 37:272-281, 1971
2. Sullivan MP, Chen T, Dyment PG, et al: Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: A pediatric oncology group study. Blood 60:948-958, 1982 (Pubitemid 12001457)
3. Pui CH, Cheng C, Leung W, et al: Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 349:640-649, 2003 (Pubitemid 36975996)
4. Hijiya N, Hudson MM, Lensing S, et al: Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297:1207-1215, 2007 (Pubitemid 46465729)
5. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al: Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297:2705-2715, 2007 (Pubitemid 47001096)
6. Waber DP, Turek J, Catania L, et al: Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol 25:4914-4921, 2007 (Pubitemid 350220422)
7. Pui CH, Mahmoud HH, Rivera GK, et al: Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 92:411-415, 1998 (Pubitemid 28323702)
8. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009
9. Mahmoud HH, Rivera GK, Hancock ML, et al: Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med 329:314-319, 1993 (Pubitemid 23210683)
10. Manabe A, Tsuchida M, Hanada R, et al: Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12. J Clin Oncol 19:3182-3187, 2001 (Pubitemid 32591434)
11. Reiter A, Schrappe M, Ludwig WD, et al: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122-3133, 1994 (Pubitemid 24328106)
12. Gajjar A, Harrison PL, Sandlund JT, et al: Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood 96:3381-3384, 2000
13. Howard SC, Gajjar A, Ribeiro RC, et al: Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 284:2222-2224, 2000
14. Howard SC, Gajjar AJ, Cheng C, et al: Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia. JAMA 288:2001-2007, 2002 (Pubitemid 35204690)
15. Liang DC, Hung IJ, Yang CP, et al: Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: A report from the Taiwan Pediatric Oncology Group. Leukemia 13:155-160, 1999
16. Lin WY, Liu HC, Yeh TC, et al: Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 50:523-527, 2008
17. Liang DC, Yang CP, Lin DT, et al: Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia. Leukemia 24:397-405, 2010
18. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 2002
19. Bürger B, Zimmermann M, Mann G, et al: Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: Significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 21:184-188, 2003 (Pubitemid 46606145)
20. Dutch Childhood Oncology Group, te Loo DM, Kamps WA, et al: Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: Experience of the Dutch Childhood Oncology Group. J Clin Oncol 24:2332-2336, 2006
21. Pui CH, Howard SC: Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol 9:257-268, 2008 (Pubitemid 351722945)
22. Hasegawa D, Manabe A, Ohara A, et al: The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study. Pediatr Blood Cancer 58:23-30, 2012
23. Vilmer E, Suciu S, Ferster A, et al: Long term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCG-EORTC report - Children Leukemia Cooperative Group. Leukemia 14:2257-2266, 2000 (Pubitemid 32042266)
24. Manera R, Ramirez I, Mullins J, et al: Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype. Leukemia 14:1354-1361, 2000 (Pubitemid 30599315)
25. Veerman AJ, Kamps WA, van den Berg H, et al: Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: Results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 10:957-966, 2009
26. Thyss A, Suciu S, Bertrand Y, et al: Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia: The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group. J Clin Oncol 15:1824-1830, 1997 (Pubitemid 27209510)
27. Matloub Y, Lindemulder S, Gaynon PS, et al: Intrathecal triple therapy decreases central nervous system relapse but fails to improve eventfree survival when compared with intrathecal methotrexate: Results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Blood 108:1165-1173, 2006 (Pubitemid 44232011)